logo-loader

ACADIA Pharmaceuticals Inc.

Receive alerts
Market:
NASDAQ
Market Cap:
$6.18 billion
Price
40.12 USD
Change
1.98%
52 weeks high
53.70
52 weeks low
21.04

In brief

ACADIA Pharmaceuticals (NASDAQ: ACAD) is a biopharmaceutical company focused on innovative small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. We have a pipeline of product candidates led by pimavanserin, which is in Phase III development as a potential first-in-class treatment for Parkinson's disease psychosis.